Courtagen Raises $7.5M | GenomeWeb

NEW YORK (GenomeWeb) – Next-generation sequencing-based testing firm Courtagen Life Sciences has raised $7.5 million, according to a document filed with the US Securities and Exchange Commission this week. 

The company said there were three investors in the round but did not name them. It did not say how proceeds would be used. A Courtagen spokesman said that the $7.5 million is part of a total financing round of about $17 million expected to be completed in a few weeks. He declined further comment. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.

Dec
13
Sponsored by
Agilent Technologies

This webinar will discuss a genomic strategy that detects single nucleotide variants and copy number variants in a single assay.

Dec
15
Sponsored by
PierianDx

This webinar will be an interactive roundtable discussion on established and emerging regulatory, scientific, and medical topics related to next-generation sequencing in the clinical setting.